VAPO | Vapotherm, Inc. Stock Overview

(Stock Exchange: NYSE)

Day's Range	2.1600 - 2.1600
52 Week Range	2.1000 - 2.1800
Beta	-0.36
Implied Volatility	1,026.88%
IV Rank	100.00%
Day's Volume	815
Average Volume	15,312
Shares Outstanding	6,244,940
Market Cap	13,489,070
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2018-11-14

Valuation
Profitability
Growth
Health
P/E Ratio	-0.26
Forward P/E Ratio	-5.03
EPS	-8.40
1YR Price Target	23.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	182
Country	USA
Website	VAPO

Vapotherm Inc is a medical technology company based in the United States. It is mainly engaged in the development and commercialization of its proprietary Hi-VNI technology products that are used to treat patients of all ages suffering from respiratory distress. The company offers four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox. It generates revenue primarily from sales of proprietary Precision Flow systems to hospitals through a direct sales organization in the United States and distributors in select countries outside of the United States.

VAPO's peers: BWAY, CTKB, IINN, NSPR, OPGN, RXST, TLIS, VERO

*Chart delayed

Analyzing fundamentals for VAPO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is frighteningly weak. For more detailed analysis please see VAPO Fundamentals page.

Watching at VAPO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on VAPO Technicals page.